תבנית:תרופה/טרוליסיטי 0.75 מ"ג - Trulicity 0.75 mg

× ×ª×× × ×ª×¨××¤×

×××¨×©×

××× ×× ×× × ××¡×¤××	××¨××××¡××× 1.5 ×"× - Trulicity 1.5 mg
×§×××¦× ×¤×¨××§××××××ª (ATC4)	A10BX Other blood glucose lowering drugs, excluding insulins
××¨××× ×¤×¢×× (ATC5)	*Dulaglutide 0.75MG / 0.5 ML âA10BX14 Dulaglutide 0.75MG / 0.5 ML âA10BX14 Other blood glucose lowering drugs, excl. insulins A10BX âA10BX14 7290008139397 ×× âA10BX14 Lilly technology center, indianapolis, indiana 46285, USA release , labelling , secondary packaging , bulk âA10BX14 Via a. gramsci, 731-733 , 50019, SESTO FIORENTINO, ITALY release , labelling , secondary packaging âA10BX14 Dunderrow, kinsale, country cork ireland API manufacturer âA10BX14 Schutzenstrasse 87 AND 99 -101, RAVENSBURG,GERMANY bulk âA10BX14 Dulaglutide 0.75MG / 0.5 ML âA10BX14
×¦××¨×ª ××ª×	S.C
×¦××¨×ª ××× ××	SOLUTION FOR INJECTION
××ª××××	Trulicity is indicated in adults with type 2 diabetes mellitus to improve glycaemic control as: Monotherapy: When diet and exercise alone do not provide adequate glycaemic control in patients for whom the use of metformin is considered inappropriate due to intolerance or contraindications.Add on therapy: In combination with other glucose lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/××¨××××¡××× 0.75 ×"× - Trulicity 0.75 mg
××ª×××ª ××× ××	Posology and method of administration
××ª×××××ª × ××	Contraindications
×ª××¤×¢××ª ×××××	Undesirable effects
×ª×××××ª ××× ×ª×¨××¤×ª×××ª	Interaction with other medicinal products and other forms of interaction
×©××××© ××××¨××× ××× ×§×	Pregnancy and Lactation
×¤×¨××§×××× ×××§×	Pharmacodynamic Properties
×¤×¨××§××§×× ×××§×	Pharmacokinetic Properties
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	×¢××× ××¨××¤× ××××¨× ××¢×××

×¢××× ××¦×¨××	*×¢××× ××¦×¨×× ×¢××× ××¦×¨×× ×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
××¨××××¡××× 0.75 ×"× Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	ELI LILLY & COMPANY LTD., USA
×©× ××¢× ××¨××©××	ELI LILLY ISRAEL LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 11/2014. ×¨××©××× ××ª××¨××: 09/2015
×ª××¨×× ×¢×××× ×××¨××	15/10/18

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

××£ ××ª×¨××¤×: ××¨××××¡××× 0.75 ×"× - Trulicity 0.75 mg

{{×ª×¨××¤×/××¨××××¡××× 0.75 ×"× - Trulicity 0.75 mg}}

×:

{{×ª×¨××¤×/××¨××××¡××× 0.75 ×"× - Trulicity 0.75 mg
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־15 באוקטובר 2018 ב־00:13

תבנית:תרופה/טרוליסיטי 0.75 מ"ג - Trulicity 0.75 mg

ויקיתרופות